Identifying gene mutations and specific markers prior to initiating therapy can result in better patient outcomes as well as substantial cost savings by avoiding poor drug choices and needless over prescribing.
ABL Kinase Gene Mutation Analysis; GleevecĀ® Resistance*
ALK 2p23 rearrangement by FISH
ALK Anaplastic Lymphoma Kinase -1 by IHC
ATM/CEP11 deletion 11q22.3 by FISH
BRAF Mutation Analysis by Next Generation Sequencing
EGFR Mutation Analysis by Next Generation Sequencing
GIST Panel - KIT, PDGFRA by Next Generation Sequencing
IDH1/IDH2 Mutation Analysis by Next Generation Sequencing
IgVH Somatic Hypermutation by Next Generation Sequencing
JAK2 V617F Mutation Analysis by PCR
KRAS Mutation Analysis by Next Generation Sequencing
MYD88 p.L265P Mutation Analysis by Next Generation Sequencing
Myeloid Extended Mutation Analysis Panel by Next Generation Sequencing